Tapestry
TPR
113.42
-3.33
-2.85%
Tapestry
US · TPR
#844 by market cap
Listed 1970
113.42
-3.33
-2.85%
Live - 5344 symbols - heartbeat 280s ago
· 2026-10-08 06:43
Pre-market
112.50
-0.81%
After-hours
113.42
0.00%
Overnight
113.00
-0.37%
- Market cap
- 22.62B
- P/E (TTM)i
- 15.60
- P/Bi
- 32.68
- EPSi
- 7.27
- Div yieldi
- 1.41%
- 52W posi
- 30%
Reader sentiment
Are you bullish or bearish on TPR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.95, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.17% YoY
Margins
- Gross margin
- 77.82%
- Operating margin
- 23.92%
- Net margin
- 19.09%
Key ratios & quality
- Enterprise valuei
- 24.15B
- PEG ratioi
- 0.88
- Altman Z-Scorei
- 3.95
PEG uses trailing P/E against the 3-year net income growth rate (17.74%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.03B | 4.96B | 5.75B | 6.68B | 6.66B | 6.67B | 7.01B | 8.00B |
| Gross profit | 4.05B | 3.24B | 4.08B | 4.65B | 4.71B | 4.89B | 5.29B | 6.23B |
| Selling & admin expenses | 3.23B | 3.31B | 3.11B | 3.47B | 3.54B | 3.75B | 4.02B | 4.31B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 819.70M | -73.10M | 968.00M | 1.18B | 1.17B | 1.14B | 1.27B | 1.91B |
| Pretax profit | 766.20M | -624.20M | 897.30M | 1.05B | 1.14B | 1.01B | 216.10M | 1.86B |
| Tax | 122.80M | 27.90M | 63.10M | 190.70M | 207.10M | 195.90M | 32.90M | 332.90M |
| Net profit | 643.40M | -652.10M | 834.20M | 856.30M | 936.00M | 816.00M | 183.20M | 1.53B |
| Basic EPS | 2 | -2 | 3 | 3 | 4 | 4 | 1 | 7 |
| Diluted EPS | 2.21 | -2.34 | 2.95 | 3.17 | 3.88 | 3.50 | 0.82 | 7.27 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.58B | 1.72B | 1.70B | 2.50B | 1.92B | 1.88B |
| Gross profit | 1.21B | 1.32B | 1.30B | 1.89B | 1.48B | 1.56B |
| Selling & admin expenses | 952.10M | 1.04B | 972.30M | 1.17B | 1.05B | 1.12B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 253.70M | 271.30M | 328.20M | 716.40M | 427.50M | 442.30M |
| Pretax profit | 239.10M | -594.00M | 318.70M | 697.10M | 416.00M | 428.80M |
| Tax | 35.80M | -76.90M | 43.90M | 135.80M | 72.20M | 81.00M |
| Net profit | 203.30M | -517.10M | 274.80M | 561.30M | 343.80M | 347.80M |
| Basic EPS | 1 | -2 | 1 | 3 | 2 | 2 |
| Diluted EPS | 0.95 | -2.49 | 1.28 | 2.68 | 1.65 | 1.68 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.56B | 2.55B | 3.38B | 2.57B | 2.36B | 8.80B | 2.91B | 2.88B |
| Cash & ST investments | 1.23B | 1.43B | 2.02B | 953.20M | 741.50M | 7.20B | 1.12B | 1.15B |
| Inventory | 778.30M | 736.90M | 734.80M | 994.20M | 919.50M | 824.80M | 860.70M | 826.20M |
| Total assets | 6.88B | 7.92B | 8.38B | 7.27B | 7.12B | 13.40B | 6.58B | 6.69B |
| Total current liabilities | 918.00M | 1.74B | 1.43B | 1.47B | 1.29B | 1.71B | 1.56B | 1.65B |
| Short-term debt | 800.00K | 1.10B | 319.40M | 319.90M | 322.50M | 603.10M | 315.70M | 307.80M |
| Long-term debt | 1.60B | 1.59B | 1.59B | 1.66B | 1.64B | 6.94B | 2.38B | 2.38B |
| Total liabilities | 3,363,900,000.00 | 5,647,800,000.00 | 5,123,100,000.00 | 4,979,800,000.00 | 4,839,000,000.00 | 10,499,400,000.00 | 5,722,700,000.00 | 5,999,600,000.00 |
| Total equity | 3.51B | 2.28B | 3.26B | 2.29B | 2.28B | 2.90B | 857.80M | 692.10M |
| Retained earnings | 291.60M | -992.70M | -158.50M | -1.17B | -1.22B | -722.20M | -2.56B | -3.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.86B | 2.91B | 2.62B | 2.79B | 2.72B | 2.88B |
| Cash & ST investments | 1.06B | 1.12B | 743.20M | 1.08B | 1.07B | 1.15B |
| Inventory | 873.50M | 860.70M | 1.02B | 896.40M | 843.90M | 826.20M |
| Total assets | 7.31B | 6.58B | 6.36B | 6.53B | 6.47B | 6.69B |
| Total current liabilities | 1.63B | 1.56B | 1.72B | 1.72B | 1.48B | 1.65B |
| Short-term debt | 600.50M | 315.70M | 565.40M | 331.00M | 310.30M | 307.80M |
| Long-term debt | 2.38B | 2.38B | 2.38B | 2.38B | 2.38B | 2.38B |
| Total liabilities | 5,812,400,000.00 | 5,722,700,000.00 | 5,963,800,000.00 | 5,979,800,000.00 | 5,784,300,000.00 | 5,999,600,000.00 |
| Total equity | 1.49B | 857.80M | 399.50M | 551.20M | 682.40M | 692.10M |
| Retained earnings | -1.91B | -2.56B | -3.36B | -3.29B | -3.17B | -3.21B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 792.40M | 407.00M | 1.32B | 853.20M | 975.20M | 1.26B | 1.22B | 1.98B |
| Depreciation & amortization | 268.20M | 248.30M | 218.70M | 206.00M | 224.20M | 229.00M | 224.90M | 217.20M |
| Free cash flow | 518.20M | 201.60M | 1.21B | 759.30M | 791.00M | 1.15B | 1.09B | 1.81B |
| Dividends paid | -390.70M | -380.30M | 0 | -264.40M | -283.30M | -321.40M | -299.30M | -326.10M |
| Stock buybacks / issuance | -100.00M | -300.00M | 0 | -1.60B | -703.50M | 0 | -2.02B | -1.55B |
| Ending cash balance | 969.20M | 1.43B | 2.01B | 789.80M | 726.10M | 6.14B | 1.10B | 974.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 144.30M | 446.80M | 112.60M | 1.08B | 262.60M | 522.20M |
| Depreciation & amortization | 53.00M | 61.50M | 51.60M | 53.10M | 53.90M | 58.60M |
| Free cash flow | 113.40M | 411.50M | 80.20M | 1.04B | 225.80M | 469.00M |
| Dividends paid | -72.70M | -72.80M | -83.30M | -81.30M | -81.00M | -80.50M |
| Stock buybacks / issuance | -2.30M | -3.40M | -698.20M | -403.50M | -150.20M | -302.70M |
| Ending cash balance | 1.04B | 1.10B | 719.50M | 1.05B | 1.05B | 974.70M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.04 | -22.53 | 30.14 | 30.89 | 41.02 | 31.54 | 9.76 | 197.14 |
| ROA %i | 9.49 | -8.81 | 10.23 | 10.94 | 13.02 | 7.96 | 1.83 | 23.02 |
| ROIC %i | 12.92 | -10.24 | 13.38 | 14.77 | 17.25 | 10.64 | 3.11 | 33.46 |
| 5-year avg ROE %i | 17.35 | 9.57 | 12.03 | 14.05 | 19.71 | 22.21 | 28.67 | 62.07 |
| EBIT margin %i | 13.51 | -11.37 | 16.86 | 16.54 | 17.58 | 17.04 | 4.30 | 23.93 |
| FCF / sales %i | 8.59 | 4.06 | 21.02 | 11.36 | 11.88 | 17.19 | 15.60 | 22.64 |
| Current ratioi | 2.79 | 1.47 | 2.37 | 1.75 | 1.84 | 5.14 | 1.87 | 1.75 |
| Quick ratioi | 1.73 | 0.96 | 1.73 | 0.97 | 0.92 | 4.48 | 1.05 | 1.01 |
| Debt / assetsi | 23.30 | 56.64 | 40.99 | 44.89 | 46.26 | 65.42 | 59.25 | 59.07 |
| LT debt / equityi | 45.59 | 148.82 | 95.62 | 128.70 | 130.37 | 281.73 | 417.75 | 526.69 |
| Interest coveragei | -- | -9.39 | 13.57 | 18.84 | 42.42 | 9.10 | 3.53 | 34.71 |
| Revenue CAGR (3Y) %i | 10.30 | 3.40 | -0.76 | 3.51 | 10.32 | 5.10 | 1.60 | 6.32 |
| Net income CAGR (3Y) %i | 11.79 | -- | 28.03 | 10.00 | -- | -0.73 | -40.19 | 17.74 |
| FCF CAGR (3Y) %i | 13.62 | -29.31 | 18.27 | 13.58 | 57.72 | -1.71 | 12.94 | 31.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 40.27 | 9.76 | 16.05 | 55.34 | 60.91 | 197.14 |
| ROA %i | 8.17 | 1.83 | 2.70 | 7.58 | 9.62 | 23.02 |
| ROIC %i | 10.72 | 3.11 | 4.04 | 11.47 | 13.89 | 33.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.17 | 4.30 | 5.22 | 9.60 | 11.41 | 23.93 |
| FCF / sales %i | 12.97 | 15.60 | 14.99 | 21.86 | 22.35 | 22.64 |
| Current ratioi | 1.76 | 1.87 | 1.52 | 1.63 | 1.84 | 1.75 |
| Quick ratioi | 0.98 | 1.05 | 0.79 | 0.96 | 1.11 | 1.01 |
| Debt / assetsi | 56.22 | 59.25 | 65.99 | 60.38 | 60.67 | 59.07 |
| LT debt / equityi | 234.78 | 417.75 | 909.61 | 655.42 | 529.44 | 526.69 |
| Interest coveragei | 11.00 | 3.53 | 5.58 | 11.94 | 15.42 | 34.71 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Coach is the largest reported line at 86.39% of revenue, across 3 reported segments.
- The next-largest line, Kate Spade, is a distant second at 13.43% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Coach86.39%
Kate Spade13.43%
Stuart Weitzman0.18%
Region
United States58.69%
Other18.02%
Greater China17.47%
Japan5.82%
Quote time 2026-10-08 06:43:10 · For reference only, not investment advice and not tailored to your situation.